Confounding effects of metformin on the human gut microbiome in Type 2 diabetes
Övrig text i vetenskaplig tidskrift, 2016

Type 2 diabetes (T2D) is associated with dysbiosis of the gut microbiota, though diabetes treatment regimens, including metformin, may confound the results. Forslund et al. (2015) identify distinct disease and drug signatures and highlight the importance of adjusting for treatment when investigating how T2D influences the human gut microbiome.

Författare

Adil Mardinoglu

Kungliga Tekniska Högskolan (KTH)

Chalmers, Biologi och bioteknik, Systembiologi

Jan Borén

Göteborgs universitet

Ulf Smith

Göteborgs universitet

Sahlgrenska universitetssjukhuset

Cell Metabolism

1550-4131 (ISSN)

Vol. 23 1 10-12

Ämneskategorier

Cell- och molekylärbiologi

DOI

10.1016/j.cmet.2015.12.012

Mer information

Senast uppdaterat

2021-07-28